{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:36:20Z","timestamp":1793284580035,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["SL200020"],"award-info":[{"award-number":["SL200020"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007408","name":"Medical Center, University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007408","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030715","name":"UPMC Hillman Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030715","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"US Office of Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["SL200020P1"],"award-info":[{"award-number":["SL200020P1"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ard.2026.05.022","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T19:48:54Z","timestamp":1781725734000},"page":"2219-2232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Autologous stem cell transplantation (ASCT) for Refractory juvenile-onset systemic sclerosis (JSSc)"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1662-143X","authenticated-orcid":false,"given":"Kathryn S.","family":"Torok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Horvei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0916-6678","authenticated-orcid":false,"given":"Jonathan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Rosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie L.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Rose-felker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibha","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Hogue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vickie","family":"Vandergrift","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Stanczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Miglioretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Farver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Koster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin","family":"Mcguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley","family":"Havrilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawna","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn T.","family":"Domsic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Lafyatis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Szabolcs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ard.2026.05.022_bib0001","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.3389\/fimmu.2019.01352","article-title":"Immunopathogenesis of juvenile systemic sclerosis","volume":"10","author":"Stevens","year":"2019","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.ard.2026.05.022_bib0002","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/rheumatology\/ken388","article-title":"Factors affecting survival in juvenile systemic sclerosis","volume":"48","author":"Martini","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.ard.2026.05.022_bib0003","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1002\/acr.23547","article-title":"Clinical characteristics and factors associated with disability and impaired quality of life in children with juvenile systemic sclerosis: results from the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry","volume":"70","author":"Stevens","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8","key":"10.1016\/j.ard.2026.05.022_bib0004","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11926-020-00910-x","article-title":"Treatment in juvenile scleroderma","volume":"22","author":"Zulian","year":"2020","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.ard.2026.05.022_bib0005","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.imlet.2017.11.005","article-title":"Autologous hematopoietic stem cell transplantation in systemic sclerosis: A reset to tolerance?","volume":"195","author":"van Rhijn-Brouwer","year":"2018","journal-title":"Immunol Lett"},{"key":"10.1016\/j.ard.2026.05.022_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.941011","article-title":"Reconstitution of the immune system and clinical correlates after stem cell transplantation for systemic sclerosis","volume":"13","author":"Kawashima-Vasconcelos","year":"2022","journal-title":"Front Immunol"},{"issue":"9790","key":"10.1016\/j.ard.2026.05.022_bib0007","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","article-title":"Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial","volume":"378","author":"Burt","year":"2011","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.ard.2026.05.022_bib0008","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial","volume":"311","author":"Van Laar","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ard.2026.05.022_bib0009","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1703327","article-title":"Myeloablative autologous stem-cell transplantation for severe scleroderma","volume":"378","author":"Sullivan","year":"2018","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ard.2026.05.022_bib0010","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/bmt.2017.56","article-title":"Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners","volume":"52","author":"Farge","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.ard.2026.05.022_bib0011","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/acr.24785","article-title":"Clinical and molecular findings after autologous stem cell transplantation or cyclophosphamide for scleroderma: handling missing longitudinal data","volume":"75","author":"Keyes-Elstein","year":"2023","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.ard.2026.05.022_bib0012","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/art.43072","article-title":"Autologous nonmyeloablative hematopoietic stem cell transplantation for diffuse cutaneous systemic sclerosis: identifying disease risk factors for toxicity and long-term outcomes in a prospective, single-arm trial","volume":"77","author":"Georges","year":"2025","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.ard.2026.05.022_bib0013","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.bbmt.2018.01.020","article-title":"Autologous hematopoietic stem cell transplantation for systemic sclerosis: a systematic review and meta-analysis","volume":"24","author":"Shouval","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.ard.2026.05.022_bib0014","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Kowal-Bielecka","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ard.2026.05.022_bib0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/ard-2024-226430","article-title":"EULAR recommendations for the treatment of systemic sclerosis: 2023 update","volume":"84","author":"Del Galdo","year":"2025","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.ard.2026.05.022_bib0016","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/art.42861","article-title":"2023 American College of Rheumatology (ACR)\/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases","volume":"76","author":"Johnson","year":"2024","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.ard.2026.05.022_bib0017","first-page":"104","article-title":"Autologous hematological stem cell transplantation for systemic sclerosis in Israel","volume":"2","author":"Rimar","year":"2020","journal-title":"Isr Med Assoc J"},{"issue":"4","key":"10.1016\/j.ard.2026.05.022_bib0018","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/1529-0131(199904)42:4<807::AID-ANR26>3.0.CO;2-T","article-title":"Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis","volume":"42","author":"Martini","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.ard.2026.05.022_bib0019","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/ard.2003.011205","article-title":"Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT\/EULAR Registry","volume":"63","author":"Farge","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.ard.2026.05.022_bib0020","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/rheumatology\/keaa584","article-title":"Consensus-based recommendations for the management of juvenile systemic sclerosis","volume":"60","author":"Foeldvari","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.ard.2026.05.022_bib0021","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/1744666X.2023.2298354","article-title":"Best clinical practice in the treatment of juvenile systemic sclerosis: expert panel guidance - the result of the International Hamburg Consensus Meeting, December 2022","volume":"20","author":"Foeldvari","year":"2024","journal-title":"Expert Rev Clin Immunol"},{"issue":"11","key":"10.1016\/j.ard.2026.05.022_bib0022","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"3 Suppl 29","key":"10.1016\/j.ard.2026.05.022_bib0023","first-page":"S42","article-title":"Assessment of disease severity and prognosis","volume":"21","author":"Medsger","year":"2003","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"10.1016\/j.ard.2026.05.022_bib0024","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1002\/art.34652","article-title":"A preliminary disease severity score for juvenile systemic sclerosis","volume":"64","author":"La Torre","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.ard.2026.05.022_bib0025","doi-asserted-by":"crossref","DOI":"10.1002\/acr2.90008","article-title":"Longitudinal assessment of the juvenile systemic sclerosis severity score: application in the national registry for childhood onset scleroderma","volume":"8","author":"Branton","year":"2026","journal-title":"ACR Open Rheumatol"},{"issue":"5","key":"10.1016\/j.ard.2026.05.022_bib0026","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/rheumatology\/ket464","article-title":"Autologous stem cell transplantation with thiotepa-based conditioning in patients with systemic sclerosis and cardiac manifestations","volume":"53","author":"Henes","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.ard.2026.05.022_bib0027","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1620\/tjem.209.61","article-title":"Successful autologous peripheral blood stem cell transplantation using thiotepa in a patient with systemic sclerosis and cardiac involvement","volume":"209","author":"Komatsuda","year":"2006","journal-title":"Tohoku J Exp Med"},{"issue":"5","key":"10.1016\/j.ard.2026.05.022_bib0028","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.bbmt.2010.08.003","article-title":"Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States","volume":"17","author":"Hosing","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.ard.2026.05.022_bib0029","first-page":"1892","article-title":"Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies","volume":"20","author":"Clements","year":"1993","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.ard.2026.05.022_bib0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13075-019-1809-y","article-title":"Minimal clinically important differences for the modified Rodnan skin score: results from the Scleroderma Lung Studies (SLS-I and SLS-II)","volume":"21","author":"Khanna","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.ard.2026.05.022_bib0031","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01519-2022","article-title":"European Respiratory Society\/American Thoracic Society technical statement: standardisation of the measurement of lung volumes, 2023 update","volume":"62","author":"Bhakta","year":"2023","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.ard.2026.05.022_bib0032","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00289-2020","article-title":"Official ERS technical standard: Global Lung Function Initiative reference values for static lung volumes in individuals of European ancestry","volume":"57","author":"Hall","year":"2021","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.ard.2026.05.022_bib0033","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1164\/rccm.201709-1845OC","article-title":"Reliability and minimal clinically important differences of forced vital capacity: Results from the Scleroderma Lung Studies (SLS-I and SLS-II)","volume":"197","author":"Kafaja","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ard.2026.05.022_bib0034","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00016-2016","article-title":"2017 ERS\/ATS standards for single-breath carbon monoxide uptake in the lung","volume":"49","author":"Graham","year":"2017","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.ard.2026.05.022_bib0035","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00010-2017","article-title":"Official ERS technical standards: Global Lung Function Initiative reference values for the carbon monoxide transfer factor for Caucasians","volume":"50","author":"Stanojevic","year":"2017","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.ard.2026.05.022_bib0036","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/art.1780401110","article-title":"The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time","volume":"40","author":"Steen","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ard.2026.05.022_bib0037","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/art.1790040106","article-title":"The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis","volume":"4","author":"Poole","year":"1991","journal-title":"Arthritis Care Res"},{"issue":"2 Suppl 58","key":"10.1016\/j.ard.2026.05.022_bib0038","first-page":"S28","article-title":"Reliability and validity of the delta finger-to-palm (FTP), a new measure of finger range of motion in systemic sclerosis","volume":"28","author":"Torok","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ard.2026.05.022_bib0039","doi-asserted-by":"crossref","DOI":"10.1111\/joim.13689","article-title":"Mouth opening in systemic sclerosis: A longitudinal analysis from the French National Cohort Study","author":"Chaigne","year":"2023","journal-title":"J Intern Med"},{"issue":"6 Suppl 86","key":"10.1016\/j.ard.2026.05.022_bib0040","article-title":"A three-year follow-up study of the development of joint contractures in 131 patients with systemic sclerosis","volume":"32","author":"B\u00e1lint","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"10.1016\/j.ard.2026.05.022_bib0041","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1002\/1529-0131(199910)42:10<2213::AID-ANR25>3.0.CO;2-8","volume":"42","author":"Lovell","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ard.2026.05.022_bib0042","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","year":"2002","journal-title":"Am J Respir Crit Care Med."},{"issue":"4","key":"10.1016\/j.ard.2026.05.022_bib0043","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jpeds.2006.12.052","article-title":"Six-minute walk test in children and adolescents","volume":"150","author":"Geiger","year":"2007","journal-title":"J Pediatr"},{"issue":"9","key":"10.1016\/j.ard.2026.05.022_bib0044","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.3899\/jrheum.110225","article-title":"Minimally important differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument","volume":"38","author":"Khanna","year":"2011","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.ard.2026.05.022_bib0045","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/acr.25643","article-title":"Gastrointestinal Impact and Tool Performance in Juvenile Systemic Sclerosis Using the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract, Version 2.0 Assessment","volume":"78","author":"Stefancic","year":"2026","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"10.1016\/j.ard.2026.05.022_bib0046","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41584-023-00929-1","article-title":"Systemic sclerosis gastrointestinal dysmotility: risk factors, pathophysiology, diagnosis and management","volume":"19","author":"McMahan","year":"2023","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"10.1016\/j.ard.2026.05.022_bib0047","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/1097-0142(19871001)60:7<1651::AID-CNCR2820600738>3.0.CO;2-J","article-title":"The measurement of performance in childhood cancer patients","volume":"60","author":"Lansky","year":"1987","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.ard.2026.05.022_bib0048","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/cncr.23375","article-title":"Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation","volume":"112","author":"Sorror","year":"2008","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.ard.2026.05.022_bib0049","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s10554-025-03365-2","article-title":"The effect of hematopoietic stem cell transplantation on cardiac mechanics in systemic sclerosis","volume":"41","author":"Chen","year":"2025","journal-title":"Int J Cardiovasc Imaging"},{"issue":"10","key":"10.1016\/j.ard.2026.05.022_bib0050","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1136\/ard.2005.050187","article-title":"Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study","volume":"65","author":"Khanna","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ard.2026.05.022_bib0051","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/cncr.22799","article-title":"Interpreting clinically significant changes in patient-reported outcomes","volume":"110","author":"Ringash","year":"2007","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ard.2026.05.022_bib0052","doi-asserted-by":"crossref","first-page":"e317","DOI":"10.1016\/S1470-2045(20)30173-X","article-title":"Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Paediatric Neuro-Oncology (RAPNO) working group","volume":"21","author":"Erker","year":"2020","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ard.2026.05.022_bib0053","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3324\/haematol.2019.230128","article-title":"Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party","volume":"106","author":"Henes","year":"2021","journal-title":"Haematologica"},{"issue":"SI","key":"10.1016\/j.ard.2026.05.022_bib0054","doi-asserted-by":"crossref","first-page":"SI32","DOI":"10.1093\/rheumatology\/keac319","article-title":"Changes on chest HRCT in systemic sclerosis-related interstitial lung disease after autologous haematopoietic stem cell transplantation","volume":"62","author":"Pugnet","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ard.2026.05.022_bib0055","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X221084845","article-title":"Autologous hematopoietic stem cell transplantation modifies specific aspects of systemic sclerosis-related microvasculopathy","volume":"14","author":"Santana-Gon\u00e7alves","year":"2022","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"12","key":"10.1016\/j.ard.2026.05.022_bib0056","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1007\/s10067-023-06766-7","article-title":"Esophageal motility in systemic sclerosis before and after autologous hematopoietic cell transplantation","volume":"42","author":"Woo","year":"2023","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.ard.2026.05.022_bib0057","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/ard-2021-221925","article-title":"Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more na\u00efve state in patients with systemic sclerosis","volume":"82","author":"Adamska","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.ard.2026.05.022_bib0058","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/art.42847","article-title":"Myeloablation followed by hematopoietic stem cell transplantation and long-term normalization of systemic sclerosis molecular signatures","volume":"76","author":"Wareing","year":"2024","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"10.1016\/j.ard.2026.05.022_bib0059","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S2352-4642(24)00167-6","article-title":"Late effects after allogeneic haematopoietic cell transplantation in children and adolescents with non-malignant disorders: a retrospective cohort study","volume":"8","author":"Kahn","year":"2024","journal-title":"Lancet Child Adolesc Health"},{"issue":"8","key":"10.1016\/j.ard.2026.05.022_bib0060","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/art.42850","article-title":"Outcomes of patients with diffuse systemic sclerosis eligible for autologous stem cell transplantation treated with conventional therapy","volume":"76","author":"Gregory","year":"2024","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.ard.2026.05.022_bib0061","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-044483","article-title":"A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol","volume":"11","author":"Spierings","year":"2021","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.ard.2026.05.022_bib0062","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/1744666X.2025.2474216","article-title":"Guidance for stem cell therapy for juvenile systemic sclerosis patients","volume":"21","author":"Foeldvari","year":"2025","journal-title":"Expert Rev Clin Immunol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496726002992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496726002992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:08:13Z","timestamp":1793282893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496726002992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":62,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0003496726002992"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2026.05.022","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autologous stem cell transplantation (ASCT) for Refractory juvenile-onset systemic sclerosis (JSSc)","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2026.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}